B7-33 is a synthetic, 27-amino-acid fragment derived from the human relaxin-2 hormone. It selectively activates the RXFP1 receptor, mimicking relaxin’s anti-fibrotic, vasodilatory, and anti-inflammatory effects without off-target hormonal activity. This makes it a promising therapeutic candidate for fibrosis, heart failure, and wound healing.